← Back to patent-cliff list
伊班膦酸钠/胆骨化醇
Tier C — Watch / tradeIbandronate Sodium Hydrate/Colecalciferol
Alvogen
Originator
2013
First approval
-
Expiry (public)
No sales data
Peak sales
化学药
Type
Targets：VDR、Bone resorption factor、FDPS
Brand：Bonviva Plus
Indications (approved)：骨质疏松症
Regional status
US
-
EU
-
China
-
Japan
-
Synthetic routes & intermediates
Routes not yet onboarded — the daily pipeline enriches by priority (approved small molecules first); this page updates automatically.
Frequently asked questions
What are the approved indications of Ibandronate Sodium Hydrate/Colecalciferol?
Approved indications include: 骨质疏松症.
When does the Ibandronate Sodium Hydrate/Colecalciferol patent expire?
No public expiry year is available for Ibandronate Sodium Hydrate/Colecalciferol yet; this page updates once verified.
How do I get a quote for Ibandronate Sodium Hydrate/Colecalciferol intermediates?
Open the CAS profile of the target intermediate from this page, or submit an RFQ directly — the CAS enters the matching flow automatically and the supply network responds with quotes.
Source: cross-verified data (structured fields only) · 2026-09-24